Literature DB >> 18061341

Alzheimer's disease-related changes in diseases characterized by elevation of intracranial or intraocular pressure.

Peter Wostyn1, Kurt Audenaert, Peter Paul De Deyn.   

Abstract

In this review, we focus on the coexistence of Alzheimer's disease-related changes in brain diseases, such as normal pressure hydrocephalus and traumatic brain injury, and in glaucoma at the level of the retinal ganglion cells. This is a group of diseases that affect central nervous system tissue and are characterized by elevation of intracranial or intraocular pressure and/or local shear stress and strain. In considering possible mechanisms underlying Alzheimer-type changes in these diseases, we briefly summarize recent evidence indicating that caspase activation and abnormal processing of beta-amyloid precursor protein, which are important events in Alzheimer's disease, may play a role both in glaucoma and following traumatic brain injury. With regard to normal pressure hydrocephalus, evidence suggests that changes in cerebrospinal fluid circulatory dynamics ultimately may result in reduced clearance of neurotoxins, such as beta-amyloid peptides and tau protein, that play a role in the pathogenesis of Alzheimer's disease. Data presented in this review could be interpreted to suggest that Alzheimer-type changes in these diseases may result at least in part from exposure of central nervous system tissue to increased levels of mechanical stress. Evidence for such a relationship is of major importance because it may support an association between elevated mechanical load and the development of Alzheimer-type lesions. Further studies are warranted, however, especially to elucidate the role of elevated mechanical forces in Alzheimer's disease neuropathogenesis.

Entities:  

Mesh:

Year:  2007        PMID: 18061341     DOI: 10.1016/j.clineuro.2007.10.011

Source DB:  PubMed          Journal:  Clin Neurol Neurosurg        ISSN: 0303-8467            Impact factor:   1.876


  16 in total

1.  Brain ventricular volume and cerebrospinal fluid biomarkers of Alzheimer's disease.

Authors:  Brian R Ott; Ronald A Cohen; Assawin Gongvatana; Ozioma C Okonkwo; Conrad E Johanson; Edward G Stopa; John E Donahue; Gerald D Silverberg
Journal:  J Alzheimers Dis       Date:  2010       Impact factor: 4.472

2.  Effect of the Aβ aggregation modulator MRZ-99030 on retinal damage in an animal model of glaucoma.

Authors:  T E Salt; S Nizari; M F Cordeiro; H Russ; W Danysz
Journal:  Neurotox Res       Date:  2014-08-09       Impact factor: 3.911

3.  Distribution of amyloid precursor protein and amyloid-beta in ocular hypertensive C57BL/6 mouse eyes.

Authors:  Anna Kipfer-Kauer; Stuart J McKinnon; Beatrice E Frueh; David Goldblum
Journal:  Curr Eye Res       Date:  2010-09       Impact factor: 2.424

4.  Alzheimer's disease and glaucoma: imaging the biomarkers of neurodegenerative disease.

Authors:  Denise A Valenti
Journal:  Int J Alzheimers Dis       Date:  2011-01-05

5.  Microtubule-associated protein tau in bovine retinal photoreceptor rod outer segments: comparison with brain tau.

Authors:  Akio Yamazaki; Yuji Nishizawa; Isao Matsuura; Fumio Hayashi; Jiro Usukura; Vladimir A Bondarenko
Journal:  Biochim Biophys Acta       Date:  2013-05-24

Review 6.  Molecular complexity of primary open angle glaucoma: current concepts.

Authors:  Kunal Ray; Suddhasil Mookherjee
Journal:  J Genet       Date:  2009-12       Impact factor: 1.166

7.  Confocal scanning laser tomography of the optic nerve head on the patients with Alzheimer's disease compared to glaucoma and control.

Authors:  Sevda Aydin Kurna; Gokcen Akar; Ahmet Altun; Yasemin Agirman; Eren Gozke; Tomris Sengor
Journal:  Int Ophthalmol       Date:  2014-10-05       Impact factor: 2.031

8.  Choroidal Proteins Involved in Cerebrospinal Fluid Production may be Potential Drug Targets for Alzheimer's Disease Therapy.

Authors:  Peter Wostyn; Kurt Audenaert; Peter Paul De Deyn
Journal:  Perspect Medicin Chem       Date:  2011-02-23

9.  Increased Cerebrospinal Fluid Production as a Possible Mechanism Underlying Caffeine's Protective Effect against Alzheimer's Disease.

Authors:  Peter Wostyn; Debby Van Dam; Kurt Audenaert; Peter Paul De Deyn
Journal:  Int J Alzheimers Dis       Date:  2011-05-26

Review 10.  Neurodegeneration of the retina in mouse models of Alzheimer's disease: what can we learn from the retina?

Authors:  Kin Chiu; Tin-Fung Chan; Andrew Wu; Irene Yan-Pui Leung; Kwok-Fai So; Raymond Chuen-Chung Chang
Journal:  Age (Dordr)       Date:  2011-05-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.